Inxmed (Shanghai) Co., Ltd.
Records under this name other than patents Inxmed (Shanghai) Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Inxmed (Shanghai) Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,257,251 | Use of Fak Inhibitor in Preparation of Drug for Treating Tumors Having Nras Mutation Formerly held In force · High confidence | In force | High confidence | |
| US 12,059,421 | Use of BI853520 in Cancer Treatment Formerly held In force · High confidence | In force | High confidence | |
| US 12,097,200 | Combination of BI853520 with chemotherapeutic drugs Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,121,519 | Use of BI853520 in Cancer Treatment Formerly held In force · High confidence | In force | High confidence | |
| US 11,999,719 | Solid Form of Compound Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,115,160 | Combined Use of IN10018 and PLD Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,986,477 | Drug combination and use for treating tumors Formerly held In force · USPTO record | In force | USPTO record |